Copyright Reports & Markets. All rights reserved.

Global NK Cell Therapy Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of NK Cell Therapy by Type
    • 1.3.1 Overview: Global NK Cell Therapy Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global NK Cell Therapy Consumption Value Market Share by Type in 2025
    • 1.3.3 NK Cell Therapy
    • 1.3.4 CAR-NK Cell Therapy
  • 1.4 Global NK Cell Therapy Market by Application
    • 1.4.1 Overview: Global NK Cell Therapy Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Cancer
    • 1.4.3 Infectious Diseases
    • 1.4.4 Gastrointestinal Diseases
    • 1.4.5 Beauty and Anti-Aging
    • 1.4.6 Others
  • 1.5 Global NK Cell Therapy Market Size & Forecast
  • 1.6 Global NK Cell Therapy Market Size and Forecast by Region
    • 1.6.1 Global NK Cell Therapy Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global NK Cell Therapy Market Size by Region, (2021-2032)
    • 1.6.3 North America NK Cell Therapy Market Size and Prospect (2021-2032)
    • 1.6.4 Europe NK Cell Therapy Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific NK Cell Therapy Market Size and Prospect (2021-2032)
    • 1.6.6 South America NK Cell Therapy Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa NK Cell Therapy Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Nektar Therapeutics
    • 2.1.1 Nektar Therapeutics Details
    • 2.1.2 Nektar Therapeutics Major Business
    • 2.1.3 Nektar Therapeutics NK Cell Therapy Product and Solutions
    • 2.1.4 Nektar Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Nektar Therapeutics Recent Developments and Future Plans
  • 2.2 ImmunityBio, Inc
    • 2.2.1 ImmunityBio, Inc Details
    • 2.2.2 ImmunityBio, Inc Major Business
    • 2.2.3 ImmunityBio, Inc NK Cell Therapy Product and Solutions
    • 2.2.4 ImmunityBio, Inc NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 ImmunityBio, Inc Recent Developments and Future Plans
  • 2.3 GC Cell
    • 2.3.1 GC Cell Details
    • 2.3.2 GC Cell Major Business
    • 2.3.3 GC Cell NK Cell Therapy Product and Solutions
    • 2.3.4 GC Cell NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 GC Cell Recent Developments and Future Plans
  • 2.4 Affimed
    • 2.4.1 Affimed Details
    • 2.4.2 Affimed Major Business
    • 2.4.3 Affimed NK Cell Therapy Product and Solutions
    • 2.4.4 Affimed NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Affimed Recent Developments and Future Plans
  • 2.5 Innate Pharma SA
    • 2.5.1 Innate Pharma SA Details
    • 2.5.2 Innate Pharma SA Major Business
    • 2.5.3 Innate Pharma SA NK Cell Therapy Product and Solutions
    • 2.5.4 Innate Pharma SA NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Innate Pharma SA Recent Developments and Future Plans
  • 2.6 Fate Therapeutics
    • 2.6.1 Fate Therapeutics Details
    • 2.6.2 Fate Therapeutics Major Business
    • 2.6.3 Fate Therapeutics NK Cell Therapy Product and Solutions
    • 2.6.4 Fate Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Fate Therapeutics Recent Developments and Future Plans
  • 2.7 Glycostem Therapeutics
    • 2.7.1 Glycostem Therapeutics Details
    • 2.7.2 Glycostem Therapeutics Major Business
    • 2.7.3 Glycostem Therapeutics NK Cell Therapy Product and Solutions
    • 2.7.4 Glycostem Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Glycostem Therapeutics Recent Developments and Future Plans
  • 2.8 Dragonfly Therapeutics
    • 2.8.1 Dragonfly Therapeutics Details
    • 2.8.2 Dragonfly Therapeutics Major Business
    • 2.8.3 Dragonfly Therapeutics NK Cell Therapy Product and Solutions
    • 2.8.4 Dragonfly Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Dragonfly Therapeutics Recent Developments and Future Plans
  • 2.9 Nkarta Therapeutics
    • 2.9.1 Nkarta Therapeutics Details
    • 2.9.2 Nkarta Therapeutics Major Business
    • 2.9.3 Nkarta Therapeutics NK Cell Therapy Product and Solutions
    • 2.9.4 Nkarta Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Nkarta Therapeutics Recent Developments and Future Plans
  • 2.10 Fortress Biotech
    • 2.10.1 Fortress Biotech Details
    • 2.10.2 Fortress Biotech Major Business
    • 2.10.3 Fortress Biotech NK Cell Therapy Product and Solutions
    • 2.10.4 Fortress Biotech NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Fortress Biotech Recent Developments and Future Plans
  • 2.11 Nkure
    • 2.11.1 Nkure Details
    • 2.11.2 Nkure Major Business
    • 2.11.3 Nkure NK Cell Therapy Product and Solutions
    • 2.11.4 Nkure NK Cell Therapy Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Nkure Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global NK Cell Therapy Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of NK Cell Therapy by Company Revenue
    • 3.2.2 Top 3 NK Cell Therapy Players Market Share in 2025
    • 3.2.3 Top 6 NK Cell Therapy Players Market Share in 2025
  • 3.3 NK Cell Therapy Market: Overall Company Footprint Analysis
    • 3.3.1 NK Cell Therapy Market: Region Footprint
    • 3.3.2 NK Cell Therapy Market: Company Product Type Footprint
    • 3.3.3 NK Cell Therapy Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global NK Cell Therapy Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global NK Cell Therapy Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global NK Cell Therapy Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global NK Cell Therapy Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America NK Cell Therapy Consumption Value by Type (2021-2032)
  • 6.2 North America NK Cell Therapy Market Size by Application (2021-2032)
  • 6.3 North America NK Cell Therapy Market Size by Country
    • 6.3.1 North America NK Cell Therapy Consumption Value by Country (2021-2032)
    • 6.3.2 United States NK Cell Therapy Market Size and Forecast (2021-2032)
    • 6.3.3 Canada NK Cell Therapy Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico NK Cell Therapy Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe NK Cell Therapy Consumption Value by Type (2021-2032)
  • 7.2 Europe NK Cell Therapy Consumption Value by Application (2021-2032)
  • 7.3 Europe NK Cell Therapy Market Size by Country
    • 7.3.1 Europe NK Cell Therapy Consumption Value by Country (2021-2032)
    • 7.3.2 Germany NK Cell Therapy Market Size and Forecast (2021-2032)
    • 7.3.3 France NK Cell Therapy Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom NK Cell Therapy Market Size and Forecast (2021-2032)
    • 7.3.5 Russia NK Cell Therapy Market Size and Forecast (2021-2032)
    • 7.3.6 Italy NK Cell Therapy Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific NK Cell Therapy Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific NK Cell Therapy Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific NK Cell Therapy Market Size by Region
    • 8.3.1 Asia-Pacific NK Cell Therapy Consumption Value by Region (2021-2032)
    • 8.3.2 China NK Cell Therapy Market Size and Forecast (2021-2032)
    • 8.3.3 Japan NK Cell Therapy Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea NK Cell Therapy Market Size and Forecast (2021-2032)
    • 8.3.5 India NK Cell Therapy Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia NK Cell Therapy Market Size and Forecast (2021-2032)
    • 8.3.7 Australia NK Cell Therapy Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America NK Cell Therapy Consumption Value by Type (2021-2032)
  • 9.2 South America NK Cell Therapy Consumption Value by Application (2021-2032)
  • 9.3 South America NK Cell Therapy Market Size by Country
    • 9.3.1 South America NK Cell Therapy Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil NK Cell Therapy Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina NK Cell Therapy Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa NK Cell Therapy Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa NK Cell Therapy Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa NK Cell Therapy Market Size by Country
    • 10.3.1 Middle East & Africa NK Cell Therapy Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey NK Cell Therapy Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia NK Cell Therapy Market Size and Forecast (2021-2032)
    • 10.3.4 UAE NK Cell Therapy Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 NK Cell Therapy Market Drivers
  • 11.2 NK Cell Therapy Market Restraints
  • 11.3 NK Cell Therapy Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 NK Cell Therapy Industry Chain
  • 12.2 NK Cell Therapy Upstream Analysis
  • 12.3 NK Cell Therapy Midstream Analysis
  • 12.4 NK Cell Therapy Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global NK Cell Therapy market size was valued at US$ 593 million in 2025 and is forecast to a readjusted size of US$ 1836 million by 2032 with a CAGR of 17.7% during review period.
    Natural Killer (NK) cell therapy is an immunotherapy that utilizes NK cells, a type of cytotoxic lymphocyte, to target and destroy cancer cells or virus-infected cells. Unlike T cells, NK cells can recognize and eliminate abnormal cells without prior sensitization, making them a valuable tool for innate immune response-based treatments. NK cells can be derived from peripheral blood, umbilical cord blood, induced pluripotent stem cells, or established NK cell lines, and are often modified or expanded ex vivo before being infused into patients. This therapy is primarily being developed for oncology, with applications in hematologic malignancies and solid tumors, as well as in infectious diseases.
    The NK cell therapy market is rapidly emerging as a promising segment within the broader cell therapy landscape. It is gaining momentum due to its potential to overcome some of the limitations associated with other immunotherapies, such as CAR-T therapy, including lower risks of cytokine release syndrome and graft-versus-host disease. NK cell therapies are under extensive clinical investigation worldwide, with numerous preclinical and clinical trials targeting leukemia, lymphoma, and solid tumors. Companies and research institutions are actively exploring genetic modifications, such as CAR-NK cells, to enhance efficacy and specificity. Favorable regulatory trends in regions like the U.S., Europe, and Asia are contributing to faster development pathways and commercialization opportunities. Additionally, collaborations between biotech firms, pharmaceutical companies, and academic centers are accelerating innovation and expanding the therapeutic pipeline. Despite challenges in manufacturing scalability and persistence of NK cells in vivo, the market outlook remains positive. Investors are showing strong interest, and the next decade is expected to witness significant progress in both technical development and clinical adoption of NK cell therapies.
    This report is a detailed and comprehensive analysis for global NK Cell Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global NK Cell Therapy market size and forecasts, in consumption value ($ Million), 2021-2032
    Global NK Cell Therapy market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global NK Cell Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global NK Cell Therapy market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for NK Cell Therapy
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global NK Cell Therapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Nektar Therapeutics, ImmunityBio, Inc, GC Cell, Affimed, Innate Pharma SA, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Nkarta Therapeutics, Fortress Biotech, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    NK Cell Therapy market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    NK Cell Therapy
    CAR-NK Cell Therapy
    Market segment by Application
    Cancer
    Infectious Diseases
    Gastrointestinal Diseases
    Beauty and Anti-Aging
    Others
    Market segment by players, this report covers
    Nektar Therapeutics
    ImmunityBio, Inc
    GC Cell
    Affimed
    Innate Pharma SA
    Fate Therapeutics
    Glycostem Therapeutics
    Dragonfly Therapeutics
    Nkarta Therapeutics
    Fortress Biotech
    Nkure
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe NK Cell Therapy product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of NK Cell Therapy, with revenue, gross margin, and global market share of NK Cell Therapy from 2021 to 2026.
    Chapter 3, the NK Cell Therapy competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and NK Cell Therapy market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of NK Cell Therapy.
    Chapter 13, to describe NK Cell Therapy research findings and conclusion.

    Buy now